This document focuses on the new situation and new opportunities for Chinese pharmaceuticals going global, covering multiple aspects.
1. Background and current situation of Chinese enterprises going global: The world is currently in a period of great change, and the trend of Chinese enterprises going global is obvious, with their position in the global value chain continuously improving. Enterprises in various industries are actively expanding overseas markets, such as e-commerce, gaming, healthcare, etc., each with different target regions and profit models.
2. Reasons for the pharmaceutical industry going global: On one hand, the domestic pharmaceutical market is highly competitive, and policies such as volume-based procurement have driven down product prices. On the other hand, overseas markets are large in scale and have broad development prospects, which can bring higher profit returns to enterprises, enhance their international competitiveness, and help share R&D costs.
3. Current situation of the pharmaceutical industry going global: Among the different fields of the Chinese pharmaceutical industry going global, CRO income leads, the proportion of low-value consumables is high in the medical device sector, and the OEM model is relatively common. In terms of registration, there are differences in rules and implementation difficulties among countries.
4. Modes of pharmaceutical globalization: These include independent globalization, establishment of NewCo, License out, mergers and acquisitions, etc., each with its own advantages and risks. At present, leveraging partnerships for globalization is the mainstream model, and cross-border e-commerce platforms have also provided new development opportunities for pharmaceutical globalization.
5. Overseas market analysis: Detailed introductions are given to markets such as Russia, Southeast Asia, Vietnam, and Macau. After the withdrawal of Western companies, there are opportunities in the Russian market; Southeast Asia has a large population, rapid economic development, and rapidly growing healthcare demand; Vietnam has fast population and economic growth, great potential in the medical market, and a strong influence of traditional Chinese medicine culture; Macau has many favorable policies for the big health industry of traditional Chinese medicine, with advantages in non-pharmaceutical product registration and listing, etc.
6. Policy support: National policies strongly support the pharmaceutical industry going global. For example, the 20th CPC Central Committee's third plenary session emphasized opening up, and the "14th Five-Year Plan" for pharmaceutical industry development proposed promoting innovative product R&D and internationalization. At the same time, the implementation of RCEP has also provided a boost for the growth of traditional Chinese medicine foreign trade.
7. Yaocchi.com services: As a cooperative supply and demand data platform, Yaocchi.com provides comprehensive services across the entire industry chain from R&D to sales, including market research, enterprise cooperation, registration and declaration, etc., helping Chinese pharmaceutical companies go global.
